Literature DB >> 19085099

The use of the diaphragm instead of condoms in a phase III diaphragm trial.

Ariane van der Straten1, Helen Cheng, Jie Moore, Deborah Kacanek, Kelly Blanchard, Guy De Bruyn, Gita Ramjee, Tsungai Chipato, Elizabeth T Montgomery, Nancy Padian.   

Abstract

The MIRA trial assessed whether providing diaphragm, lubricant gel, and condoms (intervention) compared with condoms alone (control) could reduce HIV incidence among 5,039 Southern African women. Compared with the control group, the cumulative proportion of last sex acts protected by any method was higher in the intervention group (OR = 1.33; 95% CI 1.18, 1.49); however, only 36.3% of last sex acts were protected by both a male condom and a diaphragm, whereas 36.6% were protected by a diaphragm only. Product substitution (ever deciding to use a diaphragm instead of a condom in the previous 3 months) was reported at every visit by 22.4%, at some visits by 60.7%, and at none of the visits by 16.8% of these women. Women at greater risk for infection through their own or their partner's behavior or who believed the diaphragm protected against HIV were more likely to report product substitution at every visit.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19085099     DOI: 10.1007/s10461-008-9504-z

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  7 in total

1.  Vaginal practices and associations with barrier methods and gel use among Sub-Saharan African women enrolled in an HIV prevention trial.

Authors:  Ariane van der Straten; Helen Cheng; Agnes Chidanyika; Guy De Bruyn; Nancy Padian
Journal:  AIDS Behav       Date:  2010-06

2.  Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe.

Authors:  Ariane van der Straten; Helen Cheng; Alexandra M Minnis
Journal:  J Int AIDS Soc       Date:  2010-10-19       Impact factor: 5.396

Review 3.  Biological markers of sexual activity: tools for improving measurement in HIV/sexually transmitted infection prevention research.

Authors:  Maria F Gallo; Markus J Steiner; Marcia M Hobbs; Lee Warner; Denise J Jamieson; Maurizio Macaluso
Journal:  Sex Transm Dis       Date:  2013-06       Impact factor: 2.830

4.  Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.

Authors:  Barbra A Richardson; Cliff Kelly; Gita Ramjee; Thomas Fleming; Bonus Makanani; Sarah Roberts; Petina Musara; Nkhafwire Mkandawire; Thomas Moench; Anne Coletti; Lydia Soto-Torres; Salim A Karim
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

5.  'It's not about money, it's about my health': determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South Africa.

Authors:  Catherine Macphail; Sinead Delany-Moretlwe; Philippe Mayaud
Journal:  Patient Prefer Adherence       Date:  2012-08-14       Impact factor: 2.711

6.  Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa.

Authors:  Elizabeth T Montgomery; Helen Cheng; Ariane van der Straten; Agnes C Chidanyika; Naomi Lince; Kelly Blanchard; Gita Ramjee; Busisiwe Nkala; Nancy S Padian
Journal:  AIDS Behav       Date:  2009-09-10

7.  Diaphragm used with replens gel and risk of bacterial vaginosis: results from a randomized controlled trial.

Authors:  Craig R Cohen; Su-Chun Cheng; Stephen Shiboski; Tsungai Chipato; Martin Matu; James Mwangi; Monalisa E S Mutimutema; Jennifer Tuveson; Mavis Kamba; Nancy Padian; Ariane van der Straten
Journal:  Infect Dis Obstet Gynecol       Date:  2012-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.